TrialTargeted oncology2019

Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study.

Xiaonan Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.